Skip to content
healthcare.dev
Get a free key

Tiagabine Hydrochloride

NDC 0093-5031, Tiagabine Hydrochloride, tablet, film coated, from Teva Pharmaceuticals USA, Inc..

Product NDC
0093-5031
Status
Listed
Labeler
Teva Pharmaceuticals USA, Inc.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA AUTHORIZED GENERIC
Application
NDA020646
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0093-5031 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TIAGABINE HYDROCHLORIDE4 mg/1

Pharmacologic classes

Anti-epileptic Agent [EPC]; Decreased Central Nervous System Disorganized Electrical Activity [PE]

Package NDCNDC-11Package
0093-5031-560009350315630 TABLET, FILM COATED in 1 BOTTLE (0093-5031-56)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/953ef3cc-e3cb-480f-b9ea-256520fd62b8

  • NADAC price for package 00093503156

    GET /v1/drugs/nadac/00093503156

Use it

Look up 0093-5031 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0093-5031 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0093-5031. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.